FA
CVS icon

FDx Advisors’s CVS Health CVS Stock Holding History

FDx Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,298
Closed -$502K – 234
2024
Q1 		$502K Sell
6,298
-13,303
-68% -$1.02M 0.08% 204
2023
Q4 		$1.55M Buy
19,601
+5,414
+38% +$385K 0.12% 171
2023
Q3 		$991K Buy
14,187
+1,228
+9% +$87K 0.08% 227
2023
Q2 		$896K Sell
12,959
-3,974
-23% -$283K 0.05% 323
2023
Q1 		$1.58M Hold
16,933
– – 0.07% 227
2022
Q4 		$1.58M Sell
16,933
-2,669
-14% -$258K 0.07% 227
2022
Q3 		$1.87M Sell
19,602
-125
-0.6% -$12.4K 0.08% 199
2022
Q2 		$1.83M Buy
19,727
+632
+3% +$61.7K 0.07% 218
2022
Q1 		$1.93M Sell
19,095
-2,195
-10% -$231K 0.07% 217
2021
Q4 		$2.2M Buy
21,290
+3,424
+19% +$316K 0.06% 224
2021
Q3 		$1.52M Sell
17,866
-138
-0.8% -$11.6K 0.05% 259
2021
Q2 		$1.5M Sell
18,004
-855
-5% -$70K 0.05% 246
2021
Q1 		$1.42M Buy
18,859
+8,804
+88% +$641K 0.05% 219
2020
Q4 		$687K Sell
10,055
-281
-3% -$18.3K 0.03% 353
2020
Q3 		$604K Sell
10,336
-15,009
-59% -$934K 0.03% 332
2020
Q2 		$1.65M Buy
25,345
+12,625
+99% +$795K 0.09% 167
2020
Q1 		$755K Buy
12,720
+1,187
+10% +$79.2K 0.05% 235
2019
Q4 		$857K Sell
11,533
-4,053
-26% -$285K 0.05% 251
2019
Q3 		$983K Sell
15,586
-23,281
-60% -$1.38M 0.07% 212
2019
Q2 		$2.12M Buy
38,867
+78
+0.2% +$4.2K 0.08% 187
2019
Q1 		$2.09M Buy
38,789
+22,451
+137% +$1.39M 0.08% 175
2018
Q4 		$1.07M Sell
16,338
-19,246
-54% -$1.44M 0.09% 176
2018
Q3 		$2.8M Buy
35,584
+1,029
+3% +$73.6K 0.1% 149
2018
Q2 		$2.22M Sell
34,555
-27,790
-45% -$1.83M 0.08% 198
2018
Q1 		$3.88M Sell
62,345
-2,787
-4% -$200K 0.12% 142
2017
Q4 		$4.72M Sell
65,132
-4,793
-7% -$348K 0.13% 128
2017
Q3 		$5.69M Buy
69,925
+3,589
+5% +$284K 0.16% 108
2017
Q2 		$5.34M Buy
66,336
+593
+0.9% +$46.8K 0.16% 109
2017
Q1 		$5.16M Buy
65,743
+18,405
+39% +$1.47M 0.16% 115
2016
Q4 		$3.73M Buy
47,338
+17,404
+58% +$1.41M 0.11% 176
2016
Q3 		$2.66M Sell
29,934
-2,109
-7% -$199K 0.11% 150
2016
Q2 		$3.07M Sell
32,043
-709
-2% -$70.7K 0.14% 127
2016
Q1 		$3.4M Buy
32,752
+247
+0.8% +$24K 0.16% 112
2015
Q4 		$3.18M Buy
32,505
+2,059
+7% +$202K 0.14% 120
2015
Q3 		$2.94M Sell
30,446
-13,114
-30% -$1.38M 0.25% 72
2015
Q2 		$4.26M Buy
43,560
+2,960
+7% +$302K 0.21% 86
2015
Q1 		$4.19M Sell
40,600
-12,780
-24% -$1.29M 0.09% 181
2014
Q4 		$5.14M Buy
53,380
+691
+1% +$60.9K 0.31% 56
2014
Q3 		$4.19M Buy
52,689
+3,728
+8% +$294K 0.27% 64
2014
Q2 		$3.69M Buy
48,961
+14,039
+40% +$1.06M 0.24% 77
2014
Q1 		$2.61M Buy
34,922
+13,430
+62% +$949K 0.22% 99
2013
Q4 		$1.52M Buy
21,492
+1,146
+6% +$73.6K 0.15% 141
2013
Q3 		$1.16M Sell
20,346
-730
-3% -$43.5K 0.14% 154
2013
Q2 		$1.21M Buy
+21,076
New +$1.22M 0.16% 135

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

FDx Advisors's CVS Position: Q2 2024 in Review

FDx Advisors sold out of CVS Health (CVS) in Q2 2024, closing a stake of 6,298 shares — an estimated $502K sold.

FDx Advisors first reported a position in CVS in Q2 2013 and held it in 44 quarters. The position peaked at $5.69M in Q3 2017. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • FDx Advisors reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • FDx Advisors sold 6,298 CVS Health shares in Q2 2024, an estimated $502K.
  • FDx Advisors first reported a position in CVS Health in Q2 2013 and held it in 44 quarters.
  • FDx Advisors's CVS Health position peaked at $5.69M in Q3 2017.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on FDx Advisors's 13F filing for Q2 2024, filed 2 Aug 2024.